TipRanks
Pharming Group (DE:PHG)
FRANKFURT:PHG
Germany Market
PHG
Pharming Group
RESEARCH TOOLSreports

Pharming Group (PHG) Income Statement

0 Followers

Pharming Group Income Statement

Last quarter (Q2 2026), Pharming Group's total revenue was €90.21M, a decrease of -3.23% from the same quarter last year. In Q2, Pharming Group's net income was €1.64M. See Pharming Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 376.13M$ 297.20M$ 245.32M$ 205.62M$ 198.87M
Gross Profit
$ 330.63M$ 261.80M$ 220.10M$ 188.06M$ 177.73M
Operating Expenses
$ 309.75M$ 265.47M$ 242.39M$ 178.20M$ 158.72M
Depreciation and Amortization
$ 11.22M$ 16.07M$ 15.93M$ 13.19M$ 19.61M
EBITDA
$ 34.78M$ 16.32M$ 9.88M$ 33.53M$ 48.78M
Operating Income
$ 20.88M$ -3.67M$ -22.29M$ 9.86M$ 19.01M
Other Income/Expenses
$ -8.03M$ -4.83M$ 10.28M$ 5.13M$ 4.07M
Pretax Income
$ 12.85M$ -8.49M$ -12.01M$ 14.99M$ 23.08M
Net Income
$ 2.85M$ -11.84M$ -10.55M$ 13.67M$ 16.00M
Per Share Metrics
Basic EPS
$ 0.04$ -0.18$ -0.14$ 0.17$ 0.23
Diluted EPS
$ 0.04$ -0.18$ -0.14$ 0.16$ 0.21
Weighted Average Shares Outstanding
 71.32M 68.92M 65.70M 82.54M 87.64M
Weighted Average Shares Outstanding (Diluted)
 71.32M 68.92M 65.70M 84.28M 87.64M

Pharming Group Earnings and Revenue History